AMPH Financing Cash Flow
Amphastar Pharmaceuticals Inc · Financing Cash Flow
AMPH Financing Cash Flow
Latest reported-$96.46Mperiod ending
AMPH TTM Cash from Financing (-$9.37M → -$96.46M)
TTM financing cash flow
High-resolution chart · PNG
AMPH financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -96,462,000 | |
| -83,129,000 | |
| -67,425,000 | |
| -82,894,000 | |
| -101,363,000 | |
| -81,877,000 | |
| -80,953,000 | |
| -94,194,000 | |
| 15,235,000 | |
| 454,062,000 | |
| 454,093,000 | |
| 485,014,000 | |
| 384,470,000 | |
| -44,635,000 | |
| -26,439,000 | |
| -18,973,000 | |
| -21,534,000 | |
| -25,731,000 | |
| -37,018,000 | |
| -28,549,000 | |
| -15,083,000 | |
| 2,564,000 | |
| -2,246,000 | |
| -12,401,000 | |
| -13,263,000 | |
| -26,461,000 | |
| -3,783,000 | |
| 23,521,000 | |
| 45,213,000 | |
| 47,065,000 | |
| 25,008,000 | |
| 7,284,000 | |
| -16,033,000 | |
| -6,828,000 | |
| -7,718,000 | |
| -8,177,000 | |
| 10,808,000 | |
| 2,455,000 | |
| 7,140,000 | |
| 2,830,000 | |
| -14,363,000 | |
| -9,241,000 | |
| 2,237,000 | |
| -745,000 | |
| 1,504,000 | |
| 27,382,000 | |
| 32,117,000 | |
| 36,970,000 | |
| 38,801,000 | |
| -9,732,000 | |
| -9,370,000 | |
| -3,787,000 |